Bioinformatics analysis revealed that HCC patients with higher PRMT5-ISO1 levels survived for significantly shorter times, whereas higher PRMT5-ISO5 levels improved HCC patients’ poor prognosis (Figure 1B). The gene discussed is PRMT5; the disease is hepatocellular carcinoma.